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There is surprisingly little information on the
antimicrobial activity of anti-neoplastic agents and
no systematic study of this topic seems to have
been undertaken. One of the problems involved is
that many agents are available only in very small
amounts. I report here results of a preliminary
study designed to give guidelines for further
investigations.
Twenty-one anti-neoplastic agents were screened
against a total of 28 microbial strains, chosen to be
representative of 4 major groups of pathogenic
organisms, namely Gram-positive aerobic bacteria,
Gram-negative aerobic bacteria, anaerobic bacteria
and yeasts. Anti-neoplastic agents were
incorporated into plates of Isosensitest agar (10%
lysed horse blood was added when anaerobes were
tested), and each plate was inoculated with up to 21
strains using a multi-point inoculator (Denley)
giving an inoculum size of 105 bacteria.
Incubation was at 370 for 24h aerobically or 48h
anaerobically (using the GasPak system). The
strains tested had all (except for the Oxford
Staphylococcus) recently been isolated from clinical
material. The "Gram-positive" group comprised 3
Staphylococcus aureus, 3 Staphylococcus epidermidis
and 3 Streptococcus faecalis; the "Gram-negative"
group consisted of 3 Escherichia coli, 3 Klebsiella
pneumoniae and 3 Pseudomonas aeruginosa;
"yeasts" were 3 Candida albicans; "anaerobes" were
5 Clostridium difflcile, 2 Bacteroides fragilis, 1
Veillonella sp. and 1 Clostridium perfringens.
Results are shown in Table I in which the anti-
neoplastic agents have been grouped according to
the suggestions of Laurence (1973). It was not
always possible to determine the precise minimum
inhibitory concentration (MIC) for all compounds,
as there was often too little material available; for
this reason results have been expressed semi-
quantitatively to enable an overall view to be
obtained. Any compound showing + + activity or
greater was investigated further, and conventional
MIC determined (Table II). It can be seen that
mitomycin C was by far the most active compound.
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The results show that the antimicrobial activity
of anti-neoplastic agents is generally of a low order,
but not confined to any one type of agent. The
findings confirm and extend the fragmentary
reports in the literature concerning mitomycin C,
doxyrubicin, 5-fluorouracil, cytarabine and
methotrexate (Grey & Hamilton-Miller 1977,
Moody et al., 1978, Michel et al., 1979, Jacobs et
al., 1979, Wright & Matsen 1980) against a limited
range of bacteria, and 5-fluorouracil, hydroxyurea,
doxyrubicin, vinblastine, cyclophosphamide and
cytarabine against C. albicans (Land et al., 1980).
Following these results, studies on the
antimicrobial action of anti-neoplastic agents might
be more profitably confined to possible synergistic
effects with antibiotics (Moody et al., 1978) or to
their possible mutagenic effects on bacteria.
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Table I Activity of 21 anti-neoplastic agents against 4 groups of pathogenic micro-
organisms, expressed in semi-quantitative terms
Activity against indicated type oforganism
Gram-positive Gram-negative Anaerobic
Antineoplastic agent bacteria bacteria bacteria Yeasts
Alkylating agents
Carmustine 0 0 0 +
Chlorambucil 0 0 + +
Neoplatin 0 + ND 0
No activity shown by busulphan, cyclophosphamide, dibromomannitol and
melphalan.
Anti-metabolites
Aminopterin* + + + + +
Azathioprine 0 0 + 0
5-fluorouracil* + + +/+ + + + +
Methotrexate* + +/± 0 0 +
Thioguanine + + + 0
No activity shown by cytarabine, mercaptopurine.
Inhibitors ofcell division
Etoposide + 0 + 0
Vinblastine + 0 ND +
No activity shown by vincristine.
Antibiotics
Doxyrubicin 0 0 + 0
MitomycinC ++ + ++ ++++ 0
Miscellaneous
Dacarbazine + + + 0
Hydroxyurea 0 + 0 0
Procarbazine + 0 0 0
Key: + + + + represents MIC in the range 0.01 - 0.1 ugml-P
+++ 0.1 -1
++ 1-10
+ 10 - 100
+ 100 - 1000
0 > 1000
ND=not determined
aaminopterin, methotrexate and 5-fluorouracil showed significantly higher activity
against Strept faecalis than against staphylococci, hence two scores in "Gram-positive"
category.
Table II Minimum inhibitory concentrations (MIC) of four antineoplastic
compounds against different groups of bacteria
MIC against bacteria (ggml1)
Compound Range ofvalues observed
Gram-positive Gram-negative Anaerobes
Streptococcus
Staphylococci faecalis
Mitomycin C 0.06 - 0.25 0.06 0.5 - 8 0.05 - 0.5
5-fluorouracil 0.5 - 8 0.13 - 0.25 .256 10 - 100
Aminopterin 256 - 1024 8 256 - 512 1 - 10
Methotrexate 64 - 1024 8 - 16 > 1024 >100NMR SPECTROSCOPY OF TRANSPLANTED BRAIN TUMOUR 369
MICHEL, J. JACOBS, J.Y. & SACKS, T. (1979). Bactericidal
effect of combinations of antimicrobial drugs and
antineoplastic antibiotics against Gram-negative
bacilli. Antimicr. Ag. Chemoth., 16, 761.
MOODY, M.R. MORRIS, M.J., YOUNG, V.M., MOYE, L.A.
SCHIMPFF, S.C., & WIERNIK, P.H. (1978). Effect of
two cancer chemotherapeutic agents on the
antibacterial activity of three antimicrobial agents.
Antimicr. Ag. Chemoth., 14, 737.
WRIGHT, D.N. & MATSEN, J.M. (1980). Bioassay of
antibiotics in body fluids from patients receiving
cancer chemotherapeutic agents. Antimicr. Ag.
Chemoth., 17, 417.